Box 1: Recent Trump Administration Obesity Drug Initiatives In November 2025, the Trump administration announced reaching a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1s for Medicare, Medicaid, and those purchasing the drugs directly from the manufacturers through a new TrumpRx website
The powder is relatively cheap, so its not a big add on cost wise
That being said, were still waiting on additional long-term safety data for both compounds, which are still moving through Phase 3 trials
Methods vary: systemic injection, local uterine infusion, or topical application, which affects local concentration and outcomes
Copper peptides have become one of the most widely discussed cosmetic ingredients in modern skincare because they support multiple aspects of a healthy-looking complexion within a single routine
Many men notice slower flow and more nighttime bathroom trips.*